Myriad Genetics Delivers 12% Sequential Revenue Growth in March 2021 Quarter, Company Executes on Strategic Transformation Initiatives

Go back to Myriad Genetics Delivers 12% Sequential Revenue Growth in March 2021 Quarter, Company Executes on Strategic Transformation Initiatives
Illumina, Inc. (NASDAQ: ILMN) Delayed: 161.38 -0.55 (0.34%)
Previous Close $161.93    52 Week High $196.47 
Open $161.83    52 Week Low $127.10 
Day High $163.79    P/E 179.31 
Day Low $158.91    EPS $0.90 
Volume 1,791,115       

Laboratory Corp. of America Holding (NYSE: LH) Delayed: 254.43 -1.39 (0.54%)
Previous Close $255.82    52 Week High $141.32 
Open $254.13    52 Week Low $97.79 
Day High $256.73    P/E 40.71 
Day Low $253.05    EPS $6.25 
Volume 784,900       

Myriad Genetics, Inc. (NASDAQ: MYGN) Delayed: 4.50 -0.04 (0.88%)
Previous Close $4.54    52 Week High $45.34 
Open $4.54    52 Week Low $15.92 
Day High $4.62    P/E 1.93 
Day Low $4.42    EPS $2.33 
Volume 1,271,242